Oops! There was a problem with this page but we have been notified and are working hard to resolve this!
Please email email@example.com for further information or if you have any questions.
Return to Home
Actavis Acquires Worldwide Rights for Palau Pharma's Albaconazole Antifungal Agent
PARSIPPANY, N.J. and BARCELONA, SPAIN, Aug. 6, 2013 /PRNewswire/ -- Actavis, Inc. (NYSE: ACT) and Palau Pharma, S.A. to...Read entire article
Echo Pharmaceuticals Announces Phase 2 results for Namisol®, Its’ Pipeline Product for Oral Administration of Δ9-Tetrahydrocannabin...Read entire article
Tel-Aviv, Israel, March 27, 2013 - Sage's client RedHill Biopharma Ltd. (NASDAQ: RDHL; TASE: RDHL) (the “Company” or “RedHill”), an emerging Israeli biopharmaceutical company focused primar...Read entire article
If you are interested in contacting us or obtaining the contact details for one
of our offices, please use our contact page.
If you would like to make a more comprehensive business enquiry, you can send us
further details of your company using our Business Enquiry